Clinical Trial Update: Efficacy and Safety of ATB-346 Versus Placebo in Osteoarthritis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ATB-346 to placebo in osteoarthritis patients completed; efficacy and safety data reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• ATB-346

Snippet

Sponsor: Antibe Therapeutics Inc. | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED